Skip to main content

Table 2 Proportion Adherent to Oral Antidiabetic, Antihypertensive, and Lipid-Lowering Therapies in the First Year of Antidiabetic Treatment

From: Impact of pharmacy services on initial clinical outcomes and medication adherence among veterans with uncontrolled diabetes

Medication Class

Percent Adherent

p-value

Pharmacist Visit

No Pharmacist Visit

Oral Antidiabetic

72.2

68.2

< 0.0001

Antihypertensive

83.6

80.1

< 0.0001

Lipid-Lowering

59.1

53.9

< 0.0001

Oral Antidiabetic and Antihypertensive

64.6

60.9

< 0.001

Oral Antidiabetic and Lipid-Lowering

49.9

44.8

< 0.0001

Oral Antidiabetic, Antihypertensive, and Lipid-Lowering

46.9

42.5

< 0.0001

  1. Patients on each therapy (Pharmacist Visit/No Visit): OAD (5749/5749),
  2. Antihypertensive (5039/4892), Lipid-Lowering (4644/4417),
  3. OAD, Antihypertensive, and Lipid-Lowering (4188/3900)
  4. Adherence determined by achieving a PDC ≥80%